The world's health data are growing rapidly and expected to double every 73 days by the year 2020. The multi-trillion-dollar health sector is critically, and increasingly, reliant on health data for optimisation and discovery. Health data are used to make new drugs and therapies, improve healthcare delivery, inform insurance and government policies, and much more. Thousands of companies and organisations around the world buy and sell this health data for billions of dollars annually. These individually brokered deals are slow and expensive, resulting in unnecessarily inflated overheads, large barriers to entry and wasted potential from underutilization of global health data. HealthDex is the first-of-its-kind health data marketplace for health data vendors, consumers, curators and other participants to efficiently transact in the health data market. Because revenues are primarily generated from transaction fees, HealthDex aims to maximise the number of participants and trading volume on the HealthDex platform. In the process, HealthDex will enable the generation of breakthrough medical discoveries and healthcare insights that revolutionise the health of humanity.
Dr. Chris Hobson
Pharmaceutical professional & industry expert across a range of pharmaceutical functions, including health data analytics. Ex-IQVIA Principal. Directed & consulted a number of global pharmaceutical companies including LEO Pharma. Guy Bate also holds a PhD in cellular & molecular physiology, an author and an active lecturer at the University of Auckland.